Aeterna Zentaris
AEZS
#10180
Rank
HK$0.13 B
Marketcap
HK$44.50
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -HK$16.03

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -HK$15.94. In 2022 the company made an earnings per share (EPS) of -HK$36.41 a decrease over its 2021 EPS that were of -HK$14.16.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$16.03
2022-HK$36.41157.14%
2021-HK$14.16-41.48%
2020-HK$24.19-64.46%
2019-HK$68.07-240%
2018HK$48.62-122.32%
2017-HK$217.82-53.53%
2016-HK$468.70-86.71%
2015-HK$3,528-35.21%
2014-HK$5,445-216.67%
2013HK$4,668-123.3%
2012-HK$20,032-40.8%
2011-HK$33,840-6.45%
2010-HK$36,173-27.91%
2009-HK$50,176-61.61%
2008-HK$130,69183.61%
2007-HK$71,180-195.31%
2006HK$74,681178.26%
2005HK$26,838-330%
2004-HK$11,669-80.05%
2003-HK$58,49017.78%
2002-HK$49,661515.93%
2001-HK$8,063-68.6%
2000-HK$25,680119.62%
1999-HK$11,693-3.63%
1998-HK$12,134

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Spectrum Pharmaceuticals
SPPI
-HK$2.80-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.26-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
HK$23.10-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.83-280.86%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
HK$38.04-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA